Bioasis Technologies's total liabilities is $4.5M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Bioasis Technologies (BIOAF) currently reports a total liabilities of $4.5M as of November 2022. That compares with $4.6M in the prior-year period — down 2.3% year over year. Use the charts on this page to explore Bioasis Technologies's total liabilities history and peer comparisons.
Bioasis Technologies's total liabilities decreased from $4.6M to $4.5M — a 2.3% year-over-year decrease (period ending November 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Bioasis Technologies reported $4.5M in total liabilities as of November 2022. That compares with $4.6M in the prior-year period — down 2.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $4.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bioasis Technologies, and consider following BIOAF for alerts when major investors trade the stock.
Bioasis Technologies is classified in the Healthcare sector. On total liabilities, it currently shows $4.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOAF with unrelated industries.